Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
sidebar [04.02.2018]
sallieq [Publications and presentations]
sidebar [09.13.2018] (current)
sallieq [News and highlights]
Line 1: Line 1:
 ===== News and highlights ===== ===== News and highlights =====
 + 
 +Professor Marshall will be addressing the EMF Health Summit (Sept 18th - 24th).
 +
 +//New pages at..  //  [[home:​special:​emf:​aboutRF|About RF Radiation]]
 +
 +[[https://​youtu.be/​T-6dNg0oxkE|Electrosmog Radiation - Its effects on the human VDR (and beyond)]] presented by Professor Trevor Marshall to the 11th International Congress on Autoimmunity:​ Lisbon, Portugal. May 2018
 +
 +[[https://​youtu.be/​60-VAun2R6Q|Vitamin-D:​ Why Does it '​Work'​ So Well?]] presented by Professor Trevor Marshall to the 11th International Congress on Autoimmunity:​ Lisbon, Portugal. May 2018
  
-[[https://​www.youtube.com/​watch?​v=7EDqKv8nz4A|Immune Disease and the Microbiome: Healthcare in response to New Knowledge]] presented by Professor Trevor Marshall to the Predictive, Preventive and Personalized Medicine conference: Moscow, Russia. September 2016 
  
 ===== Publications and presentations ===== ===== Publications and presentations =====
Line 7: Line 14:
 |[[home:​publications:​Proal_discoverymedicine_2017|Microbe-Microbe and Host-Microbe Interactions drive inflammatory processes]] - 2017 paper in //Discovery medicine// | |[[home:​publications:​Proal_discoverymedicine_2017|Microbe-Microbe and Host-Microbe Interactions drive inflammatory processes]] - 2017 paper in //Discovery medicine// |
 |[[home:​publications:​heil_immunologic_2016|Electrosmog and immune disease]] - paper in //​Immunologic research// on modern sources of immune suppression | |[[home:​publications:​heil_immunologic_2016|Electrosmog and immune disease]] - paper in //​Immunologic research// on modern sources of immune suppression |
-  
 |[[home:​publications:​proal_discoverymedicine_2014|Inflammatory disease and the human microbiome]] - paper in //Discovery medicine// on successive infection and methods for reversal of pathogen-induced genomic dysregulation | |[[home:​publications:​proal_discoverymedicine_2014|Inflammatory disease and the human microbiome]] - paper in //Discovery medicine// on successive infection and methods for reversal of pathogen-induced genomic dysregulation |
 |[[home:​publications:​lindseth_immunologic_2013|Immunostimulation in the treatment for chronic fatigue syndrome/​myalgic encephalomyelitis]] - paper in //​Immunologic research// on the role of immunostimulation in the treatment of CFS/ME | |[[home:​publications:​lindseth_immunologic_2013|Immunostimulation in the treatment for chronic fatigue syndrome/​myalgic encephalomyelitis]] - paper in //​Immunologic research// on the role of immunostimulation in the treatment of CFS/ME |
 |[[home:​publications:​Proal_Current_2013|The human microbiome and autoimmunity]] - paper in //Current opinion in rheumatology//​ which reviews the role of chronic pathogens in "​autoimmune"​ conditions | |[[home:​publications:​Proal_Current_2013|The human microbiome and autoimmunity]] - paper in //Current opinion in rheumatology//​ which reviews the role of chronic pathogens in "​autoimmune"​ conditions |
- 
 |[[home:​publications:​proal_molecular_2011|Immunostimulation in the era of the metagenome]] - collaborative paper in //Cellular & molecular immunology// ​ | |[[home:​publications:​proal_molecular_2011|Immunostimulation in the era of the metagenome]] - collaborative paper in //Cellular & molecular immunology// ​ |
  
Line 17: Line 22:
 ==== About Marshall Protocol Recovery ==== ==== About Marshall Protocol Recovery ====
  
-Due to differences in molecular structure, each ARB is shown to have [[home:​publications:​marshall_fda_cder_2006#​tableaffinity_of_various_arbs_and_statins_for_select_nuclear_receptors|significantly different properties]] when interacting with the nuclear receptors in the immune cells. For example: where [[home:​othertreatments:​telmisartan|Telmisartan]] would quickly and completely suppress immune function, frequent dosing of Olmesartan over a prolonged period allows recovery of immune function [[home:​protocol:​olmesartan#​vitamin_d_receptor_agonist|via activation of the vitamin D receptor]].\\ Data collected since 2004 supports the hypothesis that with the addition of diligent avoidance of every form of immune suppression overall health can be maintained and the body restored to natural homeostasis. ​+Due to differences in molecular structure, each ARB is shown to have [[home:​publications:​marshall_fda_cder_2006#​tableaffinity_of_various_arbs_and_statins_for_select_nuclear_receptors|significantly different properties]] when interacting with the nuclear receptors in the immune cells. For example: where [[home:​othertreatments:​telmisartan|Telmisartan]] would quickly and completely suppress immune function, frequent dosing of Olmesartan over a prolonged period allows recovery of immune function [[home:​protocol:​olmesartan#​vitamin_d_receptor_agonist|via activation of the vitamin D receptor]].\\ Data collected since 2004 supports the hypothesis that by also diligently avoiding ​every form of immune suppressionoverall health can be maintained and the body restored to natural homeostasis. ​
  
  
Line 23: Line 28:
 ==== About Autoimmunity Research Foundation ==== ==== About Autoimmunity Research Foundation ====
  
-[[http://​autoimmunityresearch.org|Autoimmunity Research Foundation]] is a California-based non-profit organization formed to conduct scientific research into the cause and cure of autoimmune and non-autoimmune diseases, and to instruct ​the public on subjects related to disease, useful to individuals and beneficial ​to the community.+[[http://​autoimmunityresearch.org|Autoimmunity Research Foundation]] is a California-based non-profit organization formed to conduct scientific research into the cause and cure of autoimmune and non-autoimmune diseases, and inform ​the public on subjects related to disease, useful to individuals and of benefit ​to the community.
   * [[home:​arf:​timeline|History and timeline of the Autoimmunity Research Foundation]]   * [[home:​arf:​timeline|History and timeline of the Autoimmunity Research Foundation]]
  
Line 30: Line 35:
  
 The MPKB currently contains about 400 pages and draws from the best possible evidence to support its mission. As of May 2011, about 85% of those articles are complete with the remainder awaiting completion or revision. The MPKB currently contains about 400 pages and draws from the best possible evidence to support its mission. As of May 2011, about 85% of those articles are complete with the remainder awaiting completion or revision.
-  * [[home:​index#​site_map|Site Map]] 
   * [[home:​index#​incomplete_articles|Incomplete articles]]   * [[home:​index#​incomplete_articles|Incomplete articles]]
   * [[home:​patients:​tipsformpkb|Tips for using this resource]]   * [[home:​patients:​tipsformpkb|Tips for using this resource]]
 +  * [[home:​physicians:​vitamin_d_leaflet|Testing your vitamin D Metabolites]] ​
  
  
sidebar.1522711956.txt.gz · Last modified: 04.02.2018 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.